HENRY CHRISTIAN O (CIK 1263805) reported 17 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-09-16). Recent activity: Sell DNA (5,000 shares), Sell PACB (12,497 shares), Buy PACB (920,810 shares), Sell PACB (331,793 shares), Sell PACB (140,874 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-16 | Ginkgo Bioworks Holdings, Inc. (DNA) | Director | Sell | 5,000 | $35,405 |
| 2026-03-04 | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | President & CEO | Sell | 12,497 | $18,870 |
| 2026-03-03 | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | President & CEO | Buy | 920,810 | $0 |
| 2026-02-19 | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | President & CEO | Sell | 331,793 | $524,233 |
| 2026-02-19 | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | President & CEO | Sell | 140,874 | $229,625 |
| 2025-12-10 | Wave Life Sciences Ltd. (WVE) | Director | Sell | 6,445 | $82,174 |
| 2025-12-10 | Wave Life Sciences Ltd. (WVE) | Director | Buy | 42,000 | $250,740 |
| 2025-12-10 | Wave Life Sciences Ltd. (WVE) | Director | Sell | 42,000 | $535,500 |
| 2025-12-10 | Wave Life Sciences Ltd. (WVE) | Director | Buy | 15,000 | $52,500 |
| 2025-12-10 | Wave Life Sciences Ltd. (WVE) | Director | Sell | 15,000 | $211,050 |
| 2025-12-10 | Wave Life Sciences Ltd. (WVE) | Director | Buy | 30,000 | $137,700 |
| 2025-12-10 | Wave Life Sciences Ltd. (WVE) | Director | Sell | 30,000 | $540,600 |
| 2025-09-10 | Ginkgo Bioworks Holdings, Inc. (DNA) | Director | Sell | 10,000 | $109,200 |
| 2025-09-10 | Ginkgo Bioworks Holdings, Inc. (DNA) | Director | Sell | 10,000 | $110,600 |
| 2025-08-13 | Wave Life Sciences Ltd. (WVE) | Director | Buy | 12,700 | $0 |
| 2025-08-13 | Wave Life Sciences Ltd. (WVE) | Director | Sell | 9,670 | $85,193 |
| 2025-06-13 | Ginkgo Bioworks Holdings, Inc. (DNA) | Director | Buy | 10,822 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-09-16